Hydatid Disease: Long Term, Single Centre Experience
Published: 2023-09-27
Page: 256-262
Issue: 2023 - Volume 6 [Issue 2]
S. N. Jatal *
Jatal Hospital and Research Centre, Latur, India.
Sudhir Jatal
Jatal Hospital and Research Centre, Latur, Tata Hospital, Mumbai, India.
Sachin Ingle
Department of Pathology, MIMSR Medical College, Latur, India.
*Author to whom correspondence should be addressed.
Abstract
The objective of this study is to establish the diagnosis of hydatid disease and outline its surgical treatment approach. The origin of hydatid disease can often be attributed to the echinococcus granulosus tapeworm. While pulmonary hydatids have been linked to Echinococcus multilocularis. This type of infection has been extensively documented in various regions, including South Africa, South America, Iran, Australia, and New Zealand. Within India, cases of this disease have been reported in locations such as Punjab, Varanasi, Lucknow, Kashmir, Pondicherry, Madurai, and Himachal Pradesh.
The liver is the most common site for hydatid disease in 75% of cases, followed by the lung in 50% and 10% being reported in the kidney, spleen, peritoneal cavity, ovary, bones, brain and muscles. Diagnosis of hydatid disease is based on clinical signs and symptoms and radiological imaging studies.
Keywords: Hydatid disease, AIR technique, scolicidal agents